| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0014-2999(99)00786-4 |
| P698 | PubMed publication ID | 10618466 |
| P2093 | author name string | U Heinemann | |
| D Schmitz | |||
| C Rundfeldt | |||
| R Hetka | |||
| P2860 | cites work | A pore mutation in a novel KQT-like potassium channel gene in an idiopathic epilepsy family | Q28115034 |
| A potassium channel mutation in weaver mice implicates membrane excitability in granule cell differentiation | Q28115658 | ||
| Reduction of K+ uptake in glia prevents long-term depression maintenance and causes epileptiform activity. | Q33789620 | ||
| The new anticonvulsant retigabine (D-23129) acts as an opener of K+ channels in neuronal cells | Q34447899 | ||
| The inward rectifier potassium channel family. | Q36684014 | ||
| Evaluation of antiepileptic drug efficacy. A review of clinical trial design | Q40395695 | ||
| Entorhinal-hippocampal connections: a speculative view of their function | Q40485288 | ||
| Strategies in antiepileptic drug development: is rational drug design superior to random screening and structural variation? | Q40758069 | ||
| Identification and preclinical testing of novel antiepileptic compounds | Q40908835 | ||
| Ca(2+)-activated K+ currents in neurones: types, physiological roles and modulation | Q41003282 | ||
| D-23129: a potent anticonvulsant in the amygdala kindling model of complex partial seizures | Q42638756 | ||
| Cells of origin of entorhinal cortical afferents to the hippocampus and fascia dentata of the rat | Q45127850 | ||
| Synaptic and intrinsic properties of neurons of origin of the perforant path in layer II of the rat entorhinal cortex in vitro | Q48118710 | ||
| Differential electroresponsiveness of stellate and pyramidal-like cells of medial entorhinal cortex layer II. | Q48253335 | ||
| Epileptiform activity induced by lowering extracellular [Mg2+] in combined hippocampal-entorhinal cortex slices: modulation by receptors for norepinephrine and N-methyl-D-aspartate | Q48256110 | ||
| Effects of retigabine (D-23129) on different patterns of epileptiform activity induced by 4-aminopyridine in rat entorhinal cortex hippocampal slices | Q48290379 | ||
| Epileptiform activity in combined slices of the hippocampus, subiculum and entorhinal cortex during perfusion with low magnesium medium | Q48309204 | ||
| Valproate selectively reduces the persistent fraction of Na+ current in neocortical neurons | Q48381336 | ||
| Morphological and electrophysiological characterization of layer III cells of the medial entorhinal cortex of the rat. | Q48756915 | ||
| Late low magnesium-induced epileptiform activity in rat entorhinal cortex slices becomes insensitive to the anticonvulsant valproic acid | Q48875966 | ||
| Properties of a delayed rectifier potassium current in dentate granule cells isolated from the hippocampus of patients with chronic temporal lobe epilepsy | Q48934134 | ||
| The effects of D-23129, a new experimental anticonvulsant drug, on neurotransmitter amino acids in the rat hippocampus in vitro. | Q51589015 | ||
| D-23129: a new anticonvulsant with a broad spectrum activity in animal models of epileptic seizures. | Q53989493 | ||
| Paroxysmal epileptiform discharges in temporal lobe slices after prolonged exposure to low magnesium are resistant to clinically used anticonvulsants | Q56971339 | ||
| Regional and time dependent variations of low Mg2+ induced epileptiform activity in rat temporal cortex slices | Q56971348 | ||
| Synaptic and intrinsic responses of medical entorhinal cortical cells in normal and magnesium-free medium in vitro | Q69919825 | ||
| Anticonvulsant properties of D-20443 in genetically epilepsy-prone rats: prediction of clinical response | Q71526090 | ||
| The effects of anticonvulsant agents on 4-aminopyridine induced epileptiform activity in rat hippocampus in vitro | Q72237354 | ||
| Preferential neuronal loss in layer III of the entorhinal cortex in patients with temporal lobe epilepsy | Q72270730 | ||
| Characterization of the K+ channel opening effect of the anticonvulsant retigabine in PC12 cells | Q77893179 | ||
| P433 | issue | 2-3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | entorhinal cortex | Q2603645 |
| P304 | page(s) | 165-171 | |
| P577 | publication date | 1999-12-01 | |
| P1433 | published in | European Journal of Pharmacology | Q1376712 |
| P1476 | title | Retigabine strongly reduces repetitive firing in rat entorhinal cortex | |
| P478 | volume | 386 |
| Q35717049 | Clinical utility of adjunctive retigabine in partial onset seizures in adults. |
| Q36534135 | Contribution of near-threshold currents to intrinsic oscillatory activity in rat medial entorhinal cortex layer II stellate cells |
| Q35326586 | Contributions of Kv7-mediated potassium current to sub- and suprathreshold responses of rat layer II/III neocortical pyramidal neurons. |
| Q46857416 | Effects of retigabine on the neurodegeneration and extracellular glutamate changes induced by 4-aminopyridine in rat hippocampus in vivo |
| Q41942478 | Efficacy of Retigabine on Acute Limbic Seizures in Adult Rats |
| Q43071251 | Enhancing m currents: a way out for neuropathic pain? |
| Q42458970 | Expression and functional roles of Kv7/KCNQ/M-channels in rat medial entorhinal cortex layer II stellate cells |
| Q46387953 | Isobolographic characterization of interactions of retigabine with carbamazepine, lamotrigine, and valproate in the mouse maximal electroshock-induced seizure model. |
| Q44737230 | M channels containing KCNQ2 subunits modulate norepinephrine, aspartate, and GABA release from hippocampal nerve terminals. |
| Q44280661 | Neuroprotective effects of anticonvulsants in rat hippocampal slice cultures exposed to oxygen/glucose deprivation |
| Q37950518 | Novel medications for epilepsy |
| Q35102221 | Oxidative modification of M-type K(+) channels as a mechanism of cytoprotective neuronal silencing |
| Q43515162 | Progress report on new antiepileptic drugs: a summary of the Fifth Eilat Conference (EILAT V). |
| Q47848016 | Retigabine calms seizure-induced behavior following status epilepticus |
| Q34415600 | Retigabine: chemical synthesis to clinical application. |
| Q34541901 | Retigabine: in partial seizures |
| Q37761269 | Retigabine: the newer potential antiepileptic drug. |
| Q36675813 | The new KCNQ2 activator 4-Chlor-N-(6-chlor-pyridin-3-yl)-benzamid displays anticonvulsant potential. |
| Q28138343 | The novel anticonvulsant retigabine activates M-currents in Chinese hamster ovary-cells tranfected with human KCNQ2/3 subunits |
Search more.